Paclitaxel-carboplatin combination chemotherapy in advanced breast cancer: Accumulating evidence for synergy, efficacy, and safety

By Pentheroudakis G.   Razis E.   Athanassiadis A.   Pavlidis N.   Fountzilas G.  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 147-160

Humana Press, Inc

Access to resources Recommend Favorite

Intracavitary Chemotherapy (Paclitaxel/Carboplatin Liquid Crystalline Cubic Phases) for Recurrent Glioblastoma – Clinical Observations

By Eckardstein Kajetan   Reszka Regina   Kiwit Jürgen  

Journal of Neuro-Oncology, Vol. 74, Iss. 3, 2005-09 ,pp. : 305-309

Springer Publishing Company

Access to resources Recommend Favorite

A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 281-286

Science Publishers

Access to resources Recommend Favorite

Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors

By Tran Hai   Blumenschein George   Lu Charles   Meyers Christina   Papadimitrakopoulou Vali   Fossella Frank   Zinner Ralph   Madden Timothy   Smythe Lori   Puduvalli Vinay   Munden Reggie   Truong Mylene   Herbst Roy  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 4, 2004-10 ,pp. : 308-314

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness of Paclitaxel and Carboplatin Combination in Heavily Pretreated Patients with Head and Neck Cancers

By Stathopoulos G.P.   Rigatos S.   Papakostas P.   Fountzilas G.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1780-1783

Elsevier

Access to resources Recommend Favorite